JP2025512805A5 - - Google Patents
Info
- Publication number
- JP2025512805A5 JP2025512805A5 JP2024556604A JP2024556604A JP2025512805A5 JP 2025512805 A5 JP2025512805 A5 JP 2025512805A5 JP 2024556604 A JP2024556604 A JP 2024556604A JP 2024556604 A JP2024556604 A JP 2024556604A JP 2025512805 A5 JP2025512805 A5 JP 2025512805A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- membered
- alkynyl
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263323792P | 2022-03-25 | 2022-03-25 | |
| US63/323,792 | 2022-03-25 | ||
| US202363446105P | 2023-02-16 | 2023-02-16 | |
| US63/446,105 | 2023-02-16 | ||
| PCT/US2023/016177 WO2023183540A1 (en) | 2022-03-25 | 2023-03-24 | Ikzf2 degraders and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512805A JP2025512805A (ja) | 2025-04-22 |
| JP2025512805A5 true JP2025512805A5 (https=) | 2026-03-31 |
Family
ID=86185384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556604A Pending JP2025512805A (ja) | 2022-03-25 | 2023-03-24 | Ｉｋｚｆ２分解剤及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250215012A1 (https=) |
| EP (1) | EP4499649A1 (https=) |
| JP (1) | JP2025512805A (https=) |
| KR (1) | KR20250026153A (https=) |
| CN (1) | CN119731179A (https=) |
| TW (1) | TW202341988A (https=) |
| WO (1) | WO2023183540A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2024008868A (es) | 2022-01-18 | 2024-09-23 | Maze Therapeutics Inc | Inhibidores de la apolipoproteína l1 (apol1) y métodos de uso. |
| US20250129088A1 (en) * | 2022-01-29 | 2025-04-24 | Gan & Lee Pharmaceuticals Co., Ltd. | Cereblon e3 ubiquitin ligase inhibitor |
| WO2025261456A1 (zh) * | 2024-06-19 | 2025-12-26 | 甘李药业股份有限公司 | 一种雌激素受体蛋白降解靶向嵌合体化合物及其应用 |
| US12565492B2 (en) | 2024-08-09 | 2026-03-03 | Triana Biomedicines, Inc. | Anaplastic Lymphoma Kinase (ALK) degraders and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI793151B (zh) * | 2017-08-23 | 2023-02-21 | 瑞士商諾華公司 | 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途 |
| CA3123519A1 (en) * | 2019-02-15 | 2020-08-20 | Novartis Ag | Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof |
| KR20220092920A (ko) * | 2019-10-30 | 2022-07-04 | 다나-파버 캔서 인스티튜트 인크. | 헬리오스의 소분자 분해제 및 사용 방법 |
| KR20230027056A (ko) * | 2020-06-23 | 2023-02-27 | 노파르티스 아게 | 3-(1-옥소이소인돌린-2-일)피페리딘-2,6-디온 유도체를 포함하는 투약 요법 |
| JP7819176B2 (ja) * | 2020-08-03 | 2026-02-24 | ノバルティス アーゲー | ヘテロアリール置換３－（１－オキソイソインドリン－２－イル）ピペリジン－２，６－ジオン誘導体及びその使用 |
-
2023
- 2023-03-24 CN CN202380041783.5A patent/CN119731179A/zh active Pending
- 2023-03-24 KR KR1020247035795A patent/KR20250026153A/ko active Pending
- 2023-03-24 EP EP23719521.9A patent/EP4499649A1/en active Pending
- 2023-03-24 JP JP2024556604A patent/JP2025512805A/ja active Pending
- 2023-03-24 US US18/849,594 patent/US20250215012A1/en active Pending
- 2023-03-24 WO PCT/US2023/016177 patent/WO2023183540A1/en not_active Ceased
- 2023-03-24 TW TW112111194A patent/TW202341988A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025512805A5 (https=) | ||
| JP2023515479A5 (https=) | ||
| CN121487732A (zh) | 用于治疗疾病的稠环kras抑制剂 | |
| RU2350605C2 (ru) | Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ | |
| JP2013512903A5 (https=) | ||
| JP2025510834A5 (https=) | ||
| RU2009103810A (ru) | Новые соединения | |
| BR112020001695A2 (pt) | compostos macrocíclicos e usos dos mesmos | |
| JP2020510015A5 (https=) | ||
| RU2013106754A (ru) | Производное фталазинонкетона, способ его получения и его фармацевтическое применение | |
| JP2008526999A5 (https=) | ||
| RU2012127792A (ru) | Пиразолопиримидины и родственные гетероциклы как ск2 ингибиторы | |
| JP2018513832A5 (https=) | ||
| RU2015118647A (ru) | Аминопиримидиновые соединения в качестве ингибиторов содержащих т790м мутантных egfr | |
| JP2010509375A5 (https=) | ||
| RU2010111551A (ru) | Замещенные индольные производные и способы их применения | |
| JP2007505933A5 (https=) | ||
| JP2016509047A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| JP2005505618A5 (https=) | ||
| RU2012112050A (ru) | Производные дигидроптеридинона, способ их получения и фармацевтическое применение | |
| JP2006523193A5 (https=) | ||
| JP2006523192A5 (https=) | ||
| JP2011509302A5 (https=) | ||
| JP2005522439A5 (https=) |